ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) logo

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)

Get verified emails for ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) employees

About ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)

Website
Website
Employees
Employees
201-500 employees View all
Industry
Industry
pharmaceuticals
Location
Location
50 Technology Drive,Irvine,CA,US
Description
Information
ISTA Pharmaceuticals, Inc, was a rapidly growing specialty pharmaceutical company developing, marketing and selling products in the U.S. and Puerto Rico. It was the fourth largest branded prescription eye care business in the U.S. and had an emerging allergy drug franchise. Its products treated ocular inflammation and pain, glaucoma, dry eye and ocular allergies. It had a U.S. sales force of more than 165 representatives calling on ophthalmologists, optometrists and allergists. The four key products included: • BROMDAY™ (bromfenac ophthalmic solution) 0.09% for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extractions • BEPREVE® (bepotastine besilate ophthalmic solution) 1.5% for the treatment of ocular itching associated with allergic conjunctivitis • ISTALOL® (timolol maleate ophthalmic solution) 0.05% for the treatment of glaucoma • VITRASE® (hyaluronidase injection) ovine, 200 USP units/ml for use as a spreading agent In June of 2012, ISTA was acquired by Bausch + Lomb and now operates under the Pharmaceutical business of Bausch + Lomb. In July of 2013, Bausch + Lomb was acquired by Valeant.

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) Alternatives

Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals

Frequently Asked Questions about ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)

What is ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) email format?

The widely used ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) email format is {first}.{last} (e.g. [email protected]) with 61.27% adoption across the company.


What is ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) customer service number?

To contact ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) customer service number in your country click here to find.


Who is the CEO of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)?

James Knowles is the CEO of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant).


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more